Financial Statements

The decline was driven by foreign exchange losses amidst Turkish Lira devaluation.

Recorded net profit was at $57.3m in the final quarter of 2022.

For fiscal year 2022, its revenue grew to $119.8m YoY.

The company attributed the increase to the return of foreign patients.

This is following a net loss of $98m in the same period last year.